EH
WST icon

Equitable Holdings’s West Pharmaceutical WST Stock Holding History

Equitable Holdings’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-865
Closed -$260K – 1340
2024
Q3 		$260K Sell
865
-103
-11% -$31.5K ﹤0.01% 1090
2024
Q2 		$319K Sell
968
-116
-11% -$41K ﹤0.01% 974
2024
Q1 		$429K Sell
1,084
-39
-3% -$14.4K ﹤0.01% 853
2023
Q4 		$395K Buy
1,123
+95
+9% +$33.6K ﹤0.01% 845
2023
Q3 		$386K Sell
1,028
-5
-0.5% -$1.93K 0.01% 801
2023
Q2 		$395K Buy
1,033
+235
+29% +$84K 0.01% 770
2023
Q1 		$276K Buy
+798
New +$233K ﹤0.01% 823

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Equitable Holdings's WST Position: Q4 2024 in Review

Equitable Holdings sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 865 shares — an estimated $260K sold.

Equitable Holdings first reported a position in WST in Q1 2023 and held it in 7 quarters. The position peaked at $429K in Q1 2024. 747 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • Equitable Holdings reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Equitable Holdings sold 865 West Pharmaceutical shares in Q4 2024, an estimated $260K.
  • Equitable Holdings first reported a position in West Pharmaceutical in Q1 2023 and held it in 7 quarters.
  • Equitable Holdings's West Pharmaceutical position peaked at $429K in Q1 2024.
  • 747 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Equitable Holdings's 13F filing for Q4 2024, filed 12 Feb 2025.